{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anxiety", "BDNF", "CREB", "Echium amoenum", "GABAA receptors", "Inflammation"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32778988", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "25"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "10"}], "Language": ["eng"], "ELocationID": ["10.1007/s11033-020-05699-7"], "Journal": {"ISSN": "1573-4978", "JournalIssue": {"Volume": "47", "Issue": "9", "PubDate": {"Year": "2020", "Month": "Sep"}}, "Title": "Molecular biology reports", "ISOAbbreviation": "Mol Biol Rep"}, "ArticleTitle": "The role of hippocampal GABA<sub>A</sub> receptors on anxiolytic effects of Echium amoenum extract in a mice model of restraint stress.", "Pagination": {"StartPage": "6487", "EndPage": "6496", "MedlinePgn": "6487-6496"}, "Abstract": {"AbstractText": ["Echium amoenum (EA), a popular medicinal plant in Persian medicine, has anxiolytic, antioxidant, sedative, and anti-inflammatory effects. This study examined whether GABA-ergic signaling is involved in the anxiolytic effects of EA in mice. Sixty BALB/c mice (25-30\u00a0g) were divided into six groups (n\u2009=\u200910) as follows: the (I) control group received 10\u00a0ml/kg normal saline (NS). In the stress groups, the animals underwent 14 consecutive days of restraint stress (RS), and received following treatments simultaneously; (II) RS\u2009+\u2009NS; (III) RS\u2009+\u2009Diaz (Diazepam); (IV) RS\u2009+\u2009EA; (V) RS\u2009+\u2009Flu (Flumazenil)\u2009+\u2009EA; (VI) RS\u2009+\u2009Flu\u2009+\u2009Diaz. Behavioral tests including the open field test (OFT) and elevated plus maze (EPM) were performed to evaluate anxiety-like behaviors and the effects of the regimens. The plasma level of corticosterone and the hippocampal protein expressions of IL-1\u03b2, TNF-\u03b1, CREB, and BDNF, as well as p-GABA<sub>A</sub>/GABA<sub>A</sub> ratio, were also assessed. The findings revealed that chronic administration of EA alone produced anxiolytic effects in both behavioral tests, while diazepam alone or in combination with Flu failed to decrease the anxiety-like behaviors. Furthermore, the p-GABA<sub>A</sub>/GABA<sub>A</sub> and p-CREB/CREB ratios, and protein levels of BDNF were significantly increased in the EA-received group. On the other hand, plasma corticosterone levels and the hippocampal IL-1\u03b2 and TNF-\u03b1 levels were significantly decreased by EA. However, pre-treatment with GABA<sub>A</sub> receptors (GABA<sub>A</sub> Rs) antagonist, Flu, reversed the anxiolytic and molecular effects of EA in the RS-subjected animals. Our findings confirmed that alternation of GABA<sub>A</sub>R is involved in the effects of EA against RS-induced anxiety-like behaviors, HPA axis activation, and neuroinflammation."]}, "AuthorList": [{"Identifier": ["0000-0001-5349-6028"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, 5166614756, Iran."}, {"Identifier": [], "Affiliation": "Department of Physiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Farajdokht", "ForeName": "Fereshteh", "Initials": "F"}, {"Identifier": ["0000-0002-0151-4025"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, 5166614756, Iran."}], "LastName": "Vosoughi", "ForeName": "Armin", "Initials": "A"}, {"Identifier": ["0000-0002-9725-3033"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}, {"Identifier": [], "Affiliation": "Phytopharmacology Research Center, Maragheh University of Medical Sciences, Maragheh, Iran."}], "LastName": "Ziaee", "ForeName": "Mojtaba", "Initials": "M"}, {"Identifier": ["0000-0002-2590-8467"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Persian Medicine, Faculty of Persian Medicine, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Araj-Khodaei", "ForeName": "Mostafa", "Initials": "M"}, {"Identifier": ["0000-0001-9755-9422"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, 5166614756, Iran."}], "LastName": "Mahmoudi", "ForeName": "Javad", "Initials": "J"}, {"Identifier": ["0000-0003-2872-1072"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, 5166614756, Iran. Saeed.sadigetegad@gmail.com."}, {"Identifier": [], "Affiliation": "Department of Persian Medicine, Faculty of Persian Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Saeed.sadigetegad@gmail.com."}, {"Identifier": [], "Affiliation": "East-Azerbaijan Comprehensive Stroke Program, Tabriz University of Medical Sciences, Tabriz, Iran. Saeed.sadigetegad@gmail.com."}], "LastName": "Sadigh-Eteghad", "ForeName": "Saeed", "Initials": "S"}], "GrantList": [{"GrantID": "62571", "Agency": "Tabriz University of Medical Sciences (IR)", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Biol Rep", "NlmUniqueID": "0403234", "ISSNLinking": "0301-4851"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Anxiety Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Bdnf protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Brain-Derived Neurotrophic Factor"}, {"RegistryNumber": "0", "NameOfSubstance": "Creb1 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclic AMP Response Element-Binding Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "GABA-A Receptor Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-1beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, GABA-A"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "40P7XK9392", "NameOfSubstance": "Flumazenil"}, {"RegistryNumber": "56-12-2", "NameOfSubstance": "gamma-Aminobutyric Acid"}, {"RegistryNumber": "Q3JTX2Q7TU", "NameOfSubstance": "Diazepam"}, {"RegistryNumber": "W980KJ009P", "NameOfSubstance": "Corticosterone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Anti-Anxiety Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Anxiety"}, {"QualifierName": [], "DescriptorName": "Behavior Rating Scale"}, {"QualifierName": ["drug effects"], "DescriptorName": "Behavior, Animal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Brain-Derived Neurotrophic Factor"}, {"QualifierName": ["blood"], "DescriptorName": "Corticosterone"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclic AMP Response Element-Binding Protein"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Diazepam"}, {"QualifierName": ["chemistry"], "DescriptorName": "Echium"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Flumazenil"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "GABA-A Receptor Antagonists"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hippocampus"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-1beta"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, GABA-A"}, {"QualifierName": [], "DescriptorName": "Restraint, Physical"}, {"QualifierName": ["drug effects"], "DescriptorName": "Stress, Physiological"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}, {"QualifierName": ["metabolism"], "DescriptorName": "gamma-Aminobutyric Acid"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wiegner L, Hange D, Bj\u00f6rkelund C, Ahlborg G (2015) Prevalence of perceived stress and associations to symptoms of exhaustion, depression and anxiety in a working age population seeking primary care\u2014an observational study. BMC Fam Pract 16(1):38. https://doi.org/10.1186/s12875-015-0252-7", "ArticleIdList": ["10.1186/s12875-015-0252-7", "25880219", "4377029"]}, {"Citation": "Kim EJ, Pellman B, Kim JJ (2015) Stress effects on the hippocampus: a critical review. Learn Mem 22(9):411\u2013416. https://doi.org/10.1101/lm.037291.114", "ArticleIdList": ["10.1101/lm.037291.114", "26286651", "4561403"]}, {"Citation": "Lussier AL, Caruncho HJ, Kalynchuk LE (2009) Repeated exposure to corticosterone, but not restraint, decreases the number of reelin-positive cells in the adult rat hippocampus. Neurosci Lett 460(2):170\u2013174. https://doi.org/10.1016/j.neulet.2009.05.050", "ArticleIdList": ["10.1016/j.neulet.2009.05.050", "19477232"]}, {"Citation": "Miranda DO, Anatriello E, Azevedo LR, Cordeiro JF, Peria FM, Fl\u00f3ria-Santos M, Pereira-da-Silva G (2018) Elevated serum levels of proinflammatory cytokines potentially correlate with depression and anxiety in colorectal cancer patients in different stages of the antitumor therapy. Cytokine 104:72\u201377. https://doi.org/10.1016/j.cyto.2017.09.030", "ArticleIdList": ["10.1016/j.cyto.2017.09.030", "28969939"]}, {"Citation": "Tang Z, Ye G, Chen X, Pan M, Fu J, Fu T, Liu Q, Gao Z, Baldwin DS, Hou R (2018) Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder. J Affect Disord 225:593\u2013598. https://doi.org/10.1016/j.jad.2017.08.082", "ArticleIdList": ["10.1016/j.jad.2017.08.082", "28886500"]}, {"Citation": "McEown K, Treit D (2013) \u03912 GABAA receptor sub-units in the ventral hippocampus and \u03b15 GABAA receptor sub-units in the dorsal hippocampus mediate anxiety and fear memory. Neuroscience 252:169\u2013177. https://doi.org/10.1016/j.neuroscience.2013.08.012", "ArticleIdList": ["10.1016/j.neuroscience.2013.08.012", "23962649"]}, {"Citation": "McKernan R, Rosahl T, Reynolds D, Sur C, Wafford K, Atack J, Farrar S, Myers J, Cook G, Ferris P (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA A receptor \u03b1 1 subtype. Nat Neurosci 3(6):587. https://doi.org/10.1038/75761", "ArticleIdList": ["10.1038/75761", "10816315"]}, {"Citation": "Verkuyl JM, Karst H, Jo\u00ebls M (2005) GABAergic transmission in the rat paraventricular nucleus of the hypothalamus is suppressed by corticosterone and stress. Eur J Neurosci 21(1):113\u2013121. https://doi.org/10.1111/j.1460-9568.2004.03846.x", "ArticleIdList": ["10.1111/j.1460-9568.2004.03846.x", "15654848"]}, {"Citation": "Pribiag H, Stellwagen D (2013) TNF-\u03b1 downregulates inhibitory neurotransmission through protein phosphatase 1-dependent trafficking of GABAA receptors. J Neurosci 33(40):15879\u201315893. https://doi.org/10.1523/JNEUROSCI.0530-13.2013", "ArticleIdList": ["10.1523/JNEUROSCI.0530-13.2013", "24089494", "6618471"]}, {"Citation": "Chanana P, Kumar A (2016) GABA-BZD receptor modulating mechanism of panax quinquefolius against 72-h sleep deprivation induced anxiety like behavior: possible roles of oxidative stress, mitochondrial dysfunction and neuroinflammation. Front Neurosci 10:84. https://doi.org/10.3389/fnins.2016.00084", "ArticleIdList": ["10.3389/fnins.2016.00084", "27013946", "4779932"]}, {"Citation": "Nuss P (2015) Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr Dis Treat 11:165\u2013175. https://doi.org/10.2147/NDT.S58841", "ArticleIdList": ["10.2147/NDT.S58841", "25653526", "4303399"]}, {"Citation": "Atack J (2011) GABAA receptor subtype-selective modulators I \u03b12/\u03b13-selective agonists as non-sedating anxiolytics. Curr Top Med Chem 11(9):1176\u20131202. https://doi.org/10.2174/156802611795371350", "ArticleIdList": ["10.2174/156802611795371350", "21050172"]}, {"Citation": "Vinkers CH, Olivier B (2012) Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABAA receptor modulators? Adv Pharmacol Sci. https://doi.org/10.1155/2012/416864", "ArticleIdList": ["10.1155/2012/416864", "22536226", "3321276"]}, {"Citation": "Porcher C, Medina I, Gaiarsa J-L (2018) Mechanism of BDNF modulation in GABAergic synaptic transmission in healthy and disease brains. Front Cell Neurosci 12:273. https://doi.org/10.3389/fncel.2018.00273", "ArticleIdList": ["10.3389/fncel.2018.00273", "30210299", "6121065"]}, {"Citation": "Zhu G, Sun X, Yang Y, Du Y, Lin Y, Xiang J, Zhou N (2019) Reduction of BDNF results in GABAergic neuroplasticity dysfunction and contributes to late-life anxiety disorder. Behav Neurosci 133(2):212. https://doi.org/10.1037/bne0000301", "ArticleIdList": ["10.1037/bne0000301", "30714802"]}, {"Citation": "Alboni S, Tascedda F, Corsini D, Benatti C, Caggia F, Capone G, Barden N, Blom JM, Brunello N (2011) Stress induces altered CRE/CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice. Neuropharmacology 60(7\u20138):1337\u20131346. https://doi.org/10.1016/j.neuropharm.2011.01.050", "ArticleIdList": ["10.1016/j.neuropharm.2011.01.050", "21324325"]}, {"Citation": "Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59(12):1116\u20131127. https://doi.org/10.1016/j.biopsych.2006.02.013", "ArticleIdList": ["10.1016/j.biopsych.2006.02.013"]}, {"Citation": "Carbone DL, Handa RJ (2013) Sex and stress hormone influences on the expression and activity of brain-derived neurotrophic factor. Neuroscience 239:295\u2013303. https://doi.org/10.1016/j.neuroscience.2012.10.073", "ArticleIdList": ["10.1016/j.neuroscience.2012.10.073", "23211562"]}, {"Citation": "Smith MA, Makino S, Kvetnansky R, Post RM (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15(3):1768\u20131777. https://doi.org/10.1523/JNEUROSCI.15-03-01768.1995", "ArticleIdList": ["10.1523/JNEUROSCI.15-03-01768.1995", "7891134", "6578156"]}, {"Citation": "Lussier A, Romay-Tall\u00f3n R, Caruncho H, Kalynchuk L (2013) Altered GABAergic and glutamatergic activity within the rat hippocampus and amygdala in rats subjected to repeated corticosterone administration but not restraint stress. Neuroscience 231:38\u201348. https://doi.org/10.1016/j.neuroscience.2012.11.037", "ArticleIdList": ["10.1016/j.neuroscience.2012.11.037", "23206875"]}, {"Citation": "Gholamzadeh S, Zare S, Ilkhanipoor M (2009) Evaluation of the anxiolytic effect of Echium amoenum petals extract, during chronic treatment in rat. Res Pharm Sci 2(2):91\u201395"}, {"Citation": "Heidari MR, Azad EM, Mehrabani M (2006) Evaluation of the analgesic effect of Echium amoenum Fisch & CA Mey. extract in mice: possible mechanism involved. J Ethnopharmacol 103(3):345\u2013349. https://doi.org/10.1016/j.jep.2005.08.027", "ArticleIdList": ["10.1016/j.jep.2005.08.027", "16185831"]}, {"Citation": "Naseri N, Kalantar K, Amirghofran Z (2018) Anti-inflammatory activity of Echium amoenum extract on macrophages mediated by inhibition of inflammatory mediators and cytokines expression. Res Pharm Sci 13(1):73. https://doi.org/10.4103/1735-5362.220970", "ArticleIdList": ["10.4103/1735-5362.220970", "29387114", "5772084"]}, {"Citation": "Nouri M, Farajdokht F, Kuchaksaray FR, Hamedyazdan S, Araj-Khodaei M (2019) Antidepressant and anxiolytic effect of echium amoenum in restraint stress model: the role of neuroinflammation in the prefrontal cortex and hippocampus. Iran Red Crescent Med J. https://doi.org/10.5812/ircmj.95438", "ArticleIdList": ["10.5812/ircmj.95438"]}, {"Citation": "Nouri M, Farajdokht F, Torbati M, Kuchaksaray FR, Hamedyazdan S, Araj-khodaei M, Sadigh-Eteghad S (2019) A close look at echium amoenum processing, neuroactive components, and effects on neuropsychiatric disorders. Galen Med J 8:1559. https://doi.org/10.31661/gmj.v8i0.1559", "ArticleIdList": ["10.31661/gmj.v8i0.1559"]}, {"Citation": "Ranjbar A, Khorami S, Safarabadi M, Shahmoradi A, Malekirad AA, Vakilian K, Mandegary A, Abdollahi M (2006) Antioxidant activity of Iranian Echium amoenum Fisch & CA Mey flower decoction in humans: a cross-sectional before/after clinical trial. Evid Based Complement Alternat Med 3(4):469\u2013473. https://doi.org/10.1093/ecam/nel031", "ArticleIdList": ["10.1093/ecam/nel031", "17173110", "1697746"]}, {"Citation": "Gholamzadeh S, Zare S, Ilkhanipoor M (2008) Anxiolytic effect of Echium amoenum during different treatment courses. Res J Biol Sci 3(2):176\u2013178"}, {"Citation": "Medina JH, Viola H, Wolfman C, Marder M, Wasowski C, Calvo D, Paladini AC (1997) Overview\u2014flavonoids: a new family of benzodiazepine receptor ligands. Neurochem Res 22(4):419\u2013425. https://doi.org/10.1023/a:1027303609517", "ArticleIdList": ["10.1023/a:1027303609517", "9130252"]}, {"Citation": "Wasowski C, Marder M (2012) Flavonoids as GABAA receptor ligands: the whole story? J Exp Pharmacol 4:9\u201324. https://doi.org/10.2147/JEP.S23105", "ArticleIdList": ["10.2147/JEP.S23105", "27186113", "4863311"]}, {"Citation": "Abed A, Minaiyan M, Ghannadi A, Mahzouni P, Babavalian MR (2012) Effect of Echium amoenum Fisch. et Mey a traditional Iranian herbal remedy in an experimental model of acute pancreatitis. ISRN Gastroenterol 2012:141548. https://doi.org/10.5402/2012/141548", "ArticleIdList": ["10.5402/2012/141548", "23008778", "3449129"]}, {"Citation": "Rabbani M, Sajjadi S, Khalili S (2011) A lack of tolerance to the anxiolytic action of Echium amoenum. Res Pharm Sci 6(2):101\u2013106", "ArticleIdList": ["22224093", "3249772"]}, {"Citation": "Luscher B, Shen Q, Sahir N (2011) The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16(4):383\u2013406. https://doi.org/10.1038/mp.2010.120", "ArticleIdList": ["10.1038/mp.2010.120", "21079608"]}, {"Citation": "Mohammadi AB, Torbati M, Farajdokht F, Sadigh-Eteghad S, Fazljou SMB, Vatandoust SM, Golzari SE, Mahmoudi J (2019) Sericin alleviates restraint stress induced depressive-and anxiety-like behaviors via modulation of oxidative stress, neuroinflammation and apoptosis in the prefrontal cortex and hippocampus. Brain Res 1715:47\u201356. https://doi.org/10.1016/j.brainres.2019.03.020", "ArticleIdList": ["10.1016/j.brainres.2019.03.020"]}, {"Citation": "Salehpour F, Farajdokht F, Cassano P, Sadigh-Eteghad S, Erfani M, Hamblin MR, Salimi MM, Karimi P, Rasta SH, Mahmoudi J (2019) Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: reduction in oxidative stress, neuroinflammation, and apoptosis. Brain Res Bull 144:213\u2013222. https://doi.org/10.1016/j.brainresbull.2018.10.010", "ArticleIdList": ["10.1016/j.brainresbull.2018.10.010", "30385146"]}, {"Citation": "Shafaghi B, Naderi N, Tahmasb L, Kamalinejad M (2010) Anxiolytic effect of Echium amoenum L. in mice. Iran J Pharm Res 1:37\u201341"}, {"Citation": "Nicholson MW, Sweeney A, Pekle E, Alam S, Ali AB, Duchen M, Jovanovic JN (2018) Diazepam-induced loss of inhibitory synapses mediated by PLC\u03b4/Ca 2\u2009+/calcineurin signalling downstream of GABAA receptors. Mol Psychiatry 23(9):1851. https://doi.org/10.1038/s41380-018-0100-y", "ArticleIdList": ["10.1038/s41380-018-0100-y", "29904150", "6232101"]}, {"Citation": "Divljakovi\u0107 J, Mili\u0107 M, Timi\u0107 T, Savi\u0107 MM (2012) Tolerance liability of diazepam is dependent on the dose used for protracted treatment. Pharmacol Rep 64(5):1116\u20131125. https://doi.org/10.1016/s1734-1140(12)70908-8", "ArticleIdList": ["10.1016/s1734-1140(12)70908-8", "23238468"]}, {"Citation": "Fernandes C, Arnot MI, Irvine EE, Bateson AN, Martin IL, File SE (1999) The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam. Psychopharmacology 145(3):251\u2013259. https://doi.org/10.1007/s002130051056", "ArticleIdList": ["10.1007/s002130051056", "10494573"]}, {"Citation": "Zhu S, Noviello CM, Teng J, Walsh RM, Kim JJ, Hibbs RE (2018) Structure of a human synaptic GABA A receptor. Nature 559(7712):67. https://doi.org/10.1038/s41586-018-0255-3", "ArticleIdList": ["10.1038/s41586-018-0255-3", "29950725", "6220708"]}, {"Citation": "De Kloet ER, Jo\u00ebls M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6(6):463. https://doi.org/10.1038/nrn1683", "ArticleIdList": ["10.1038/nrn1683", "15891777"]}, {"Citation": "Mizoguchi K, Yuzurihara M, Ishige A, Sasaki H, Chui D-H, Tabira T (2001) Chronic stress differentially regulates glucocorticoid negative feedback response in rats. Psychoneuroendocrinology 26(5):443\u2013459. https://doi.org/10.1016/s0306-4530(01)00004-x", "ArticleIdList": ["10.1016/s0306-4530(01)00004-x", "11337130"]}, {"Citation": "Nakamura Y, Darnieder LM, Deeb TZ, Moss SJ (2015) Regulation of GABAARs by phosphorylation. Adv Pharmacol 72:97\u2013146", "ArticleIdList": ["10.1016/bs.apha.2014.11.008"]}, {"Citation": "Gottmann K, Mittmann T, Lessmann V (2009) BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses. Exp Brain Res 199(3\u20134):203\u2013234. https://doi.org/10.1007/s00221-009-1994-z", "ArticleIdList": ["10.1007/s00221-009-1994-z", "19777221"]}, {"Citation": "Bell-Horner CL, Dohi A, Nguyen Q, Dillon GH, Singh M (2006) ERK/MAPK pathway regulates GABAA receptors. J Neurobiol 66(13):1467\u20131474. https://doi.org/10.1002/neu.20327", "ArticleIdList": ["10.1002/neu.20327", "17013930"]}, {"Citation": "Obrietan K, Gao X-B, van den Pol AN (2002) Excitatory actions of GABA increase BDNF expression via a MAPK-CREB-dependent mechanism\u2014a positive feedback circuit in developing neurons. J Neurophysiol 88(2):1005\u20131015. https://doi.org/10.1152/jn.2002.88.2.1005", "ArticleIdList": ["10.1152/jn.2002.88.2.1005", "12163549"]}, {"Citation": "Lakshminarasimhan H, Chattarji S (2012) Stress leads to contrasting effects on the levels of brain derived neurotrophic factor in the hippocampus and amygdala. PLoS ONE. https://doi.org/10.1371/journal.pone.0030481", "ArticleIdList": ["10.1371/journal.pone.0030481", "23028781", "3446968"]}, {"Citation": "Maghsoudi N, Ghasemi R, Ghaempanah Z, Ardekani AM, Nooshinfar E, Tahzibi A (2014) Effect of chronic restraint stress on HPA axis activity and expression of BDNF and Trkb in the hippocampus of pregnant rats: possible contribution in depression during pregnancy and postpartum period. Basic Clin Neurosci 5(2):131\u2013137", "ArticleIdList": ["25337371", "4202592"]}, {"Citation": "Ramezany Yasuj S, Nourhashemi M, Keshavarzi S, Motaghinejad M, Motevalian M (2019) Possible role of cyclic AMP response element binding/brain-derived neurotrophic factor signaling pathway in mediating the pharmacological effects of duloxetine against methamphetamine use-induced cognitive impairment and withdrawal-induced anxiety and depression in rats. Adv Biomed Res 8:11. https://doi.org/10.4103/abr.abr_34_18", "ArticleIdList": ["10.4103/abr.abr_34_18", "30993081", "6425746"]}, {"Citation": "Stellwagen D, Beattie EC, Seo JY, Malenka RC (2005) Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-\u03b1. J Neurosci 25(12):3219\u20133228. https://doi.org/10.1523/JNEUROSCI.4486-04.2005", "ArticleIdList": ["10.1523/JNEUROSCI.4486-04.2005", "15788779", "6725093"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "4", "Day": "13"}, {"Year": "2020", "Month": "7", "Day": "26"}, {"Year": "2020", "Month": "8", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "12", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32778988", "10.1007/s11033-020-05699-7", "10.1007/s11033-020-05699-7"]}}], "PubmedBookArticle": []}